These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3865998)

  • 1. Treatment of central diabetes insipidus with DDAVP.
    Chiu WT; Shih CJ; Chen HY; Lin LS
    Taiwan Yi Xue Hui Za Zhi; 1985 Aug; 84(8):944-52. PubMed ID: 3865998
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin), a new synthetic analog of vasopressin, in the treatment of childhood diabetes insipidus].
    Lebacq E; David L
    Pediatrie; 1975; 30(3):265-270. PubMed ID: 1178251
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of vasopressin-sensitive diabetes insipidus in children with DDAVP].
    Gerards LJ; van Leeuwen EF; Donckerwolcke RA; Kuijten RH
    Ned Tijdschr Geneeskd; 1975 Aug; 119(33):1269-72. PubMed ID: 1165795
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of central diabetes insipidus using oral DDAVP. Comparison with intranasal treatment].
    Carraro A; Fano M; Porcella E; Bernareggi V; Giusti M
    Minerva Endocrinol; 1991; 16(3):141-5. PubMed ID: 1806811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
    Czakó L; Mezei G; László FA
    Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment and effects of desmopressin (DDAVP) in patients with central diabetes insipidus (author's transl)].
    Matsui K; Kimura T; Ota K; Iitake K; Yoshinaga K
    Horumon To Rinsho; 1979 Aug; 27(8):891-5. PubMed ID: 487624
    [No Abstract]   [Full Text] [Related]  

  • 7. Individual differences in the antidiuretic response induced by single doses of 1-deamino-8-D-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
    Radó JP; Marosi J; Borbély L; Takó J
    Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):259-65. PubMed ID: 1002361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-year experience with DDAVP in treatment of diabetes insipidus.
    Marek J; Loutocký A; Pacovský V; Zaoral M
    Endokrinologie; 1978 May; 72(2):188-94. PubMed ID: 738214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of diabetes insipidus with DDAVP.
    Lampert RP; Blackett PR; Rennert OM
    J Pediatr; 1978 Nov; 93(5):896-7. PubMed ID: 712511
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of diabetes insipidus with synthetic vasopressin derivatives (effect of 1-deamino-8-D-arginine vasopressin and 1-deamino-valine-8-D-arginine vasopressin)].
    Czakó L; László F; Manning M
    Orv Hetil; 1980 Mar; 121(13):773-8. PubMed ID: 7383655
    [No Abstract]   [Full Text] [Related]  

  • 11. [Schwartz-Bartter syndrome following long-term DDAVP therapy in a patient with diabetes insipidus].
    Radó J; Pató E
    Orv Hetil; 1983 May; 124(22):1323-6. PubMed ID: 6877810
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of DDAVP (1-desamino-8-D-arginine vasopressin) in children with central diabetes insipidus (author's transl)].
    Tomita M; Nakagawa S; Saito N; Sakurada N; Nonoda A
    Horumon To Rinsho; 1979 Jun; 27(6):681-5. PubMed ID: 466837
    [No Abstract]   [Full Text] [Related]  

  • 13. [The treatment of patients with diabetes insipidus by a synthetic analogue of vasopressin, DDAVP (author's transl)].
    Tanae A; Shimizu K; Yoshida S
    Nihon Naibunpi Gakkai Zasshi; 1978 May; 54(5):676-91. PubMed ID: 689212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DDAVP in the treatment of central diabetes insipidus.
    Robinson AG
    N Engl J Med; 1976 Mar; 294(10):507-11. PubMed ID: 1250255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of central diabetes insipidus in adults and children with desmopressin.
    Ziai F; Walter R; Rosenthal IM
    Arch Intern Med; 1978 Sep; 138(9):1382-5. PubMed ID: 686929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative evaluation of antidiuretic preparations used in treating diabetes insipidus patients].
    Kolomoĭskaia MB; Latypova GA
    Vrach Delo; 1984 Apr; (4):76-9. PubMed ID: 6204458
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pseudoresistance to DDAVP in diabetes insipidus].
    Radó J; Pató E; Czigner J; Fáber K
    Orv Hetil; 1985 Aug; 126(33):2043-6. PubMed ID: 4034192
    [No Abstract]   [Full Text] [Related]  

  • 18. DDAVP in the treatment of diabetes insipidus: a clinical study.
    Graham JJ; Wise PH; Harding PE
    Med J Aust; 1977 Jul; 2(4):113-6. PubMed ID: 895639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the diuretic action of glibenclamide by clofibrate, carbamazepine and 1-deamino-8-d-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
    Radó JP; Szende L; Marosi J; Juhos E; Sawinsky I; Takó J
    Acta Diabetol Lat; 1974; 11(3):179-97. PubMed ID: 4218049
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diabetes insipidus--with special reference to DDAVP therapy].
    Shimizu K
    Nihon Rinsho; 1979; 37(4):849-55. PubMed ID: 449070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.